CA2100314A1 - Pharmaceutical Composition for the Treatment of Chronic Skin Ulcers - Google Patents

Pharmaceutical Composition for the Treatment of Chronic Skin Ulcers

Info

Publication number
CA2100314A1
CA2100314A1 CA 2100314 CA2100314A CA2100314A1 CA 2100314 A1 CA2100314 A1 CA 2100314A1 CA 2100314 CA2100314 CA 2100314 CA 2100314 A CA2100314 A CA 2100314A CA 2100314 A1 CA2100314 A1 CA 2100314A1
Authority
CA
Canada
Prior art keywords
treatment
pharmaceutical composition
skin ulcers
chronic skin
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2100314
Other languages
French (fr)
Other versions
CA2100314C (en
Inventor
Pierre Rochon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2100314 priority Critical patent/CA2100314C/en
Priority to FR9408541A priority patent/FR2707497A1/en
Priority to GB9413939A priority patent/GB2280370A/en
Priority to DE19944424548 priority patent/DE4424548A1/en
Publication of CA2100314A1 publication Critical patent/CA2100314A1/en
Application granted granted Critical
Publication of CA2100314C publication Critical patent/CA2100314C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A pharmaceutical composition for the treatment of chronic skin ulcers comprises as active ingredient a mixture of 4-chloro-3,5-dimethylphenol and boric acid, together with a pharmaceutically acceptable carrier therefor. The composition of the invention is effective for clearing bacterial infection and stimulating cell growth.
CA 2100314 1993-07-12 1993-07-12 Pharmaceutical composition for the treatment of chronic skin ulcers Expired - Fee Related CA2100314C (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA 2100314 CA2100314C (en) 1993-07-12 1993-07-12 Pharmaceutical composition for the treatment of chronic skin ulcers
FR9408541A FR2707497A1 (en) 1993-07-12 1994-07-11 Pharmaceutical composition for the treatment of chronic skin ulcers.
GB9413939A GB2280370A (en) 1993-07-12 1994-07-11 Pharmaceutical composition for the treatment of chronic skin ulcers
DE19944424548 DE4424548A1 (en) 1993-07-12 1994-07-12 Pharmaceutical composition for the treatment of chronic skin ulcers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2100314 CA2100314C (en) 1993-07-12 1993-07-12 Pharmaceutical composition for the treatment of chronic skin ulcers

Publications (2)

Publication Number Publication Date
CA2100314A1 true CA2100314A1 (en) 1995-01-13
CA2100314C CA2100314C (en) 1996-04-16

Family

ID=4151918

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2100314 Expired - Fee Related CA2100314C (en) 1993-07-12 1993-07-12 Pharmaceutical composition for the treatment of chronic skin ulcers

Country Status (4)

Country Link
CA (1) CA2100314C (en)
DE (1) DE4424548A1 (en)
FR (1) FR2707497A1 (en)
GB (1) GB2280370A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100222301A1 (en) * 2010-02-06 2010-09-02 Javid Mihan Jafari Topical drug for treatment and/or prevention of diabetic neuropathy, microangiopathy and diabetic and non diabetic ulcers and wound infection

Also Published As

Publication number Publication date
FR2707497A1 (en) 1995-01-20
CA2100314C (en) 1996-04-16
DE4424548A1 (en) 1995-01-19
GB9413939D0 (en) 1994-08-31
GB2280370A (en) 1995-02-01

Similar Documents

Publication Publication Date Title
CA2274074A1 (en) Novel compounds with analgesic effect
CA2239174A1 (en) Novel compounds with analgesic effect
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
ITMI922953A1 (en) DOUBLE BIOLOGICAL ACTIVITY OF NO SYNTHASIS AND CYCLOOXYGENES PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS THAT CONTAIN THEM.
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
MY132705A (en) Novel compounds with analgesic effect
EP1466606A3 (en) Use of inosine for the manufacture of a medicament for stimulating axonal outgrowth of central nervous system neurons
AU5201493A (en) Method and pharmaceutical preparations for reducing the activity of cells
AU4697393A (en) Pharmaceutical and/or cosmetic preparation and the use of the preparation
CA2094137A1 (en) Novel hydroxamic acid and n-hydroxyurea derivatives and their use
CA2186269A1 (en) Wound healing
DE69631609D1 (en) Tricyclische erythromycinderivate
AU7001487A (en) Difluorohalomethoxyphenyl derivative and miticide comprising said derivative as active ingredient
CA2139385A1 (en) Products containing g-csf and tnf binding protein
CA2200480A1 (en) New use of prostaglandins
WO1994008613A3 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
CA2031817A1 (en) Use of thrombospondin to promote wound healing
AU7588094A (en) Dihalopropene compound, insecticide/acaricide containing said diahalopropene compound as active ingredient, and intermediate compound for use in production of said dihalopropene compound
DE69723864D1 (en) Ethyliden-derivate tricyclyscher carbapenems
EP0393707A3 (en) Bioactive compounds associated with liposomes and their use in pharmaceutical preparations
AU591892B2 (en) Peptides
CA2120319A1 (en) Pharmaceutical for the treatment of skin disorders
ITMI922742A0 (en) COMPOUNDS WITH THERAPEUTIC ACTIVITY USEFUL FOR THE TREATMENT OF DISEASES RELATED TO GLUTATHIONE DEFICIENCY, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
CA2100314A1 (en) Pharmaceutical Composition for the Treatment of Chronic Skin Ulcers

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed